L
Lunai Bioworks Inc. (LNAI)
NCM – Real vaqt narxi. Valyuta: USD
0.31
-0.01 (-3.06%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.30
-0.01 (-4.46%)
Bozor oldidan: May 13, 2026, 5:24 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.31
-0.01 (-3.06%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.30
-0.01 (-4.46%)
Bozor oldidan: May 13, 2026, 5:24 AM EDT
Lunai Bioworks Inc., preclinical bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlar va Niderlandiyaga dori-darmonlar, diagnostika va biohimoya mahsulotlarini taqdim etadi. U uchta segment orqali ishlaydi: RENB, BioSymetrics va RENC. Kompaniya genetik jihatdan o'zgartirilgan allogenik dendritik hujayrali terapevtik vaktsinalarni ishlab chiqmoqda, shu jumladan, asosan oshqozon osti bezi saratoni uchun qattiq o'smalarni davolash uchun RENB-DC11; va ko'krak bezi saratonini davolash uchun RENB-DC20. Shuningdek, u ko'p omik yondashuvdan foydalangan holda, hatto asemptomatik bemorlarda ham mavjud bo'lgan individual biomarkerni qidirish uchun saratonni erta aniqlash va uning takrorlanishi uchun sun'iy intellekt platformasi texnologiyasini ishlab chiqadi. Kompaniya ilgari Renovaro Inc. nomi bilan tanilgan va 2025 yil avgust oyida Lunai Bioworks Inc. nomini o'zgartirgan. Lunai Bioworks Inc. shtab-kvartirasi Los-Anjeles, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. David H. Weinstein | CEO & Director |
| Mr. Nathen Fuentes CPA | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-01 | DEFR14A | e7597_defr14a.htm |
| 2026-05-01 | 8-K | e7595_8k.htm |
| 2026-04-28 | DEFA14A | e7585_defa14a.htm |
| 2026-04-28 | 8-K | e7584_8-k.htm |
| 2026-04-15 | DEFR14A | e7558_defr14a.htm |
| 2026-04-13 | DEF 14A | e7555_def14a.htm |
| 2026-04-02 | PRE 14A | e7522_pre14a.htm |
| 2026-03-30 | 8-K | e7507_8-k.htm |
| 2026-03-05 | 8-K | e7401_8-k.htm |
| 2026-02-23 | 8-K | e7360_8-k.htm |